Correlation Between Cigna Corp and Singular Genomics

Can any of the company-specific risk be diversified away by investing in both Cigna Corp and Singular Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cigna Corp and Singular Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cigna Corp and Singular Genomics Systems, you can compare the effects of market volatilities on Cigna Corp and Singular Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cigna Corp with a short position of Singular Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cigna Corp and Singular Genomics.

Diversification Opportunities for Cigna Corp and Singular Genomics

-0.55

Correlation Coefficient

Cigna Corp  Singular Genomics

Excellent diversification

The 3 months correlation between Cigna and Singular is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Cigna Corp and Singular Genomics Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Singular Genomics Systems and Cigna Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cigna Corp are associated (or correlated) with Singular Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Singular Genomics Systems has no effect on the direction of Cigna Corp i.e., Cigna Corp and Singular Genomics go up and down completely randomly.

Pair Corralation between Cigna Corp and Singular Genomics

Allowing for the 90-day total investment horizon Cigna Corp is expected to under-perform the Singular Genomics. But the stock apears to be less risky and, when comparing its historical volatility, Cigna Corp is 10.34 times less risky than Singular Genomics. The stock trades about -0.06 of its potential returns per unit of risk. The Singular Genomics Systems is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  628.00  in Singular Genomics Systems on September 1, 2024 and sell it today you would earn a total of  1,562  from holding Singular Genomics Systems or generate 248.73% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Cigna Corp  vs.  Singular Genomics Systems

Cigna Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cigna Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest abnormal performance, the Stock's forward indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Singular Genomics Systems

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Singular Genomics Systems are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak forward indicators, Singular Genomics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cigna Corp and Singular Genomics

The main advantage of trading using opposite Cigna Corp and Singular Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cigna Corp position performs unexpectedly, Singular Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Singular Genomics will offset losses from the drop in Singular Genomics' long position.

The idea behind Cigna Corp and Singular Genomics Systems pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.